UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000007483
Receipt No. R000008826
Scientific Title Etiological analysis of chronic cough
Date of disclosure of the study information 2012/03/10
Last modified on 2012/03/12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Etiological analysis of chronic cough
Acronym Etiology of chronic cough
Scientific Title Etiological analysis of chronic cough
Scientific Title:Acronym Etiology of chronic cough
Region
Japan

Condition
Condition Chronic cough
Classification by specialty
Pneumology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To elucidate the causes of chronic cough by the systematic treating cascade
Basic objectives2 Others
Basic objectives -Others To analyse the beta-agonist responsive cough
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes To clarify the etiology of chronic cough
Key secondary outcomes To categorize beta-agonist responsive cough

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
78 years-old >=
Gender Male and Female
Key inclusion criteria Consecutively resister patients who visit cough clinic
Key exclusion criteria Patients who can not finish the protocol
Target sample size 184

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Mitsusi Okazawa
Organization Fujita Health University
Division name Respiratory medicine and clinical allergy
Zip code
Address 1-98 Dengakugakubo Kutsukakecho Toyoake
TEL 0562-93-9003
Email

Public contact
Name of contact person
1st name
Middle name
Last name Mitsushi Okazawa
Organization Fujita Health University
Division name Respiratory medicine and clinical allergy
Zip code
Address 1-98 Dengakugakubo Kutsukakecho Toyoake
TEL 0562-93-9003
Homepage URL
Email mokazawa@fujita-hu.ac.jp

Sponsor
Institute Respiratory medicine and clinical allergy
Institute
Department

Funding Source
Organization Fujita Health University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 03 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2004 Year 04 Month 01 Day
Date of IRB
Anticipated trial start date
2004 Year 04 Month 01 Day
Last follow-up date
2007 Year 12 Month 01 Day
Date of closure to data entry
2007 Year 12 Month 01 Day
Date trial data considered complete
2007 Year 12 Month 01 Day
Date analysis concluded
2008 Year 12 Month 01 Day

Other
Other related information To clarify the etiology of chronic cough, Procaterol inhalation, oral administration of Clarithromycin plus Carbocysteine, Cetirizine and Rabeprazole were systematically administered.

Management information
Registered date
2012 Year 03 Month 10 Day
Last modified on
2012 Year 03 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008826

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.